Teon Therapeutics Inc. Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Teon Therapeutics Inc. is a clinical-stage biotechnology company focused on metabolic signaling pathways and the development of GPCR immunotherapies for cancers that are difficult to treat. Its work centers on small molecules that influence the tumor microenvironment to counter immunosuppressive signaling, aiming to support anti-tumor immune activity. The company’s target market comprises oncology researchers and clinicians seeking novel therapeutic approaches for challenging cancers, with a focus on immuno-oncology applications. Teon is based in Redwood City, California, and operates with a small team, pursuing collaborations to advance its clinical programs, including a noted clinical trial collaboration with Merck established in early 2023. The firm positions itself within the biotechnology research sector as a developer of targeted metabolic and GPCR-related cancer therapies, pursuing a focused portfolio and clinical development pathway.